Paul A. Offit, MD, discusses his latest book on the stories behind medical innovation

Video

Paul A. Offit, MD, pulls back the curtain on medical discoveries in "You Bet Your Life: From Blood Transfusions to Mass Vaccination, the Long and Risky History of Medical Innovation"

The long and winding road to new innovations in medicine, from vaccines to complex organ transplants, are not paved in gold. Quite the opposite. In his latest book, Paul A. Offit, MD, director of the Vaccine Education Center and professor of Pediatrics in the Division of Infectious Diseases at Children's Hospital of Philadelphia, discusses the sobering reality behind medical discovery.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jillian Cotter, MD
Related Content
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD

Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD

Octavio Ramilo, MD
June 20th 2025
Article

Octavio Ramilo, MD, joins us once again to discuss potential benefits of RSV vaccination beyond disease prevention, and to explain how to speak with patients about vaccines and uptake.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age | Image credit: Contemporary Pediatrics

FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age

Joshua Fitch, Senior Editor
June 12th 2025
Article

Glecaprevir/pibrentasvir was a "highly efficacious treatment for people with acute HCV," with 96.2% of patients analyzed having sustained virological response 12 weeks post-treatment.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels | Image Credit: © Monir - © Monir - stock.adobe.com.

Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels

Joshua Fitch, Senior Editor
June 5th 2025
Article

Six-month results from the phase 2 VLA1553-221 trial aligned with initial data and demonstrated immune response at day 180 among patients aged 1 to 11 years.

County-level data set reveals widespread decline in MMW vaccination rates in the United States | Image Credit: © Leigh Prather - © Leigh Prather - stock.adobe.com.

County-level data set reveals widespread decline in MMR vaccination rates in the United States

Joshua Fitch, Senior Editor
June 4th 2025
Article

The data found complements state- and national-level CDC data, confirming widespread declines in MMR vaccination rates.

© 2025 MJH Life Sciences

All rights reserved.